It has previously been demonstrated that miR-221/222 down-regulate E-cadherin through targeting of the 3′UTR of TRPS1 (trichorhinophalangeal syndrome type 1), a transcriptional repressor that inhibits EMT through repressing ZEB2 [38]. Here, TRPS1 is linked to trichorhinophalangeal syndrome type I.